Onderneming DexCom, Inc.
Aandelen
DXCM
US2521311074
Medische apparatuur, benodigdheden & distributie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
136,2 USD | +1,68% | +2,54% | +10,61% |
22/04 | John Chevedden dient een aandeelhoudersvoorstel in bij DexCom | CI |
22/04 | Myra K. Young dient een aandeelhoudersvoorstel in bij DexCom | CI |
Vakgebied
De Verenigde Staten zijn goed voor 72,5% van de netto-omzet.
Aantal werknemers: 9 550
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Distributor
85,5
%
| 2 471 | 84,9 % | 3 096 | 85,5 % | +25,29% |
Direct
14,5
%
| 439 | 15,1 % | 527 | 14,5 % | +19,98% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
72,5
%
| 2 142 | 73,6 % | 2 625 | 72,5 % | +22,56% |
International
27,5
%
| 768 | 26,4 % | 997 | 27,5 % | +29,85% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01-11-07 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 01-09-18 |
Chief Tech/Sci/R&D Officer | 47 | 01-10-22 | |
Shelly Selvaraj
CTO | Chief Tech/Sci/R&D Officer | 65 | 01-05-16 |
Jacob Leach
COO | Chief Operating Officer | 46 | 01-03-04 |
Don Abbey
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-05-16 |
Andrew Balo
CTO | Chief Tech/Sci/R&D Officer | 76 | 01-02-02 |
Sean Christensen
IRC | Investor Relations Contact | - | - |
Paul Flynn
PRN | Corporate Officer/Principal | 55 | 01-10-15 |
Sadie Stern
HRO | Human Resources Officer | 49 | 01-09-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 20-11-09 |
Mark Foletta
BRD | Director/Board Member | 63 | 19-11-14 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-09 |
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01-11-07 |
Steven Altman
BRD | Director/Board Member | 62 | 07-11-13 |
Bridgette Heller
BRD | Director/Board Member | 62 | 13-09-19 |
Richard Collins
BRD | Director/Board Member | 67 | 09-03-17 |
Kyle Malady
BRD | Director/Board Member | 56 | 11-10-20 |
Barbara Kahn
BRD | Director/Board Member | 71 | 01-04-11 |
Karen Dahut
BRD | Director/Board Member | 60 | 11-08-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 407 315 421 | 383 967 012 ( 94,27 %) | 21 800 000 ( 5,352 %) | 94,27 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Dexcom Operating Ltd.
Dexcom Operating Ltd. Financial ConglomeratesFinance Part of DexCom, Inc., DexCom Operating Ltd. functions as an investment holding British company. The private company is based in Reading, UK and was founded in 2015. |
Financial Conglomerates
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,61% | 53,07 mld. | |
-3,26% | 187 mld. | |
-2,47% | 108 mld. | |
-4,13% | 67,71 mld. | |
+15,60% | 47,36 mld. | |
+6,01% | 39,73 mld. | |
+10,57% | 28,56 mld. | |
+1,23% | 26,55 mld. | |
+15,97% | 25,13 mld. | |
+0,18% | 24,97 mld. |
- Beurs
- Aandelen
- Koers DXCM
- Onderneming DexCom, Inc.